Publications by authors named "John Fullarton"

Claim this Profile
C
Cost-effectiveness of wastewater and environmental monitoring of respiratory syncytial virus to guide universal infant immunoprophylaxis in Canada.
Élisabeth Mercier, John R Fullarton, Bosco A Paes, Ian P Keary, Barry S Rodgers-Gray

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Pandemic Dynamics of the Global Circulation of Human Metapneumovirus and Respiratory Syncytial Virus.
Marie-Noëlle Billard, Joanne G Wildenbeest, Ruben Kole, Barry Rodgers-Gray, John Fullarton

J Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing risk factors to guide COST-effective use of palivizumab in KOREAN infants.
Ji-Man Kang, Xavier Carbonell-Estrany, Bosco Paes, Barry Rodgers-Gray, John Fullarton

Pediatr Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants.
Bosco Paes, Marcello Lanari, Barry Rodgers-Gray, John Fullarton, Xavier Carbonell-Estrany

Front Pediatr· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age.
Ian P Keary, Roberto Ravasio, John R Fullarton, Paolo Manzoni, Marcello Lanari

PLoS One· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of oral prolonged-release mesalazine in moderately active ulcerative colitis.
Kristine Paridaens, John R Fullarton, Simon P L Travis

JGH Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurately Assessing the Expected Impact of Universal First Respiratory Syncytial Virus (RSV) Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants.
John Fullarton, Ian Keary, Bosco Paes, Jean-Eric Tarride, Xavier Carbonell-Estrany

J Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants.
Barry S Rodgers-Gray, John R Fullarton, Xavier Carbonell-Estrany, Ian P Keary, Jean-Éric Tarride

J Med Econ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis.
Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John R Fullarton

Intest Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries.
Xavier Carbonell-Estrany, Eric A F Simões, Louis J Bont, Angela Gentile, Nusrat Homaira, John R Fullarton

Front Pediatr· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis.
Axel U Dignass, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, Jae Hee Cheon, John R Fullarton

Scand J Gastroenterol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of oral Pentasa (prolonged-release mesalazine) in mild-to-moderate ulcerative colitis: a systematic review and meta-analysis.
Kristine Paridaens, John R Fullarton, Simon P L Travis

Curr Med Res Opin· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoption in Canada of an international risk scoring tool to predict respiratory syncytial virus hospitalization in moderate-to-late preterm infants.
Bosco Paes, John R Fullarton, Barry S Rodgers-Gray, Xavier Carbonell-Estrany

Curr Med Res Opin· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of 5-aminosalicylates in Crohn's disease: a retrospective study using the UK Clinical Practice Research Datalink.
Ailsa Hart, Siew C Ng, John Watkins, Kristine Paridaens, James O Edwards, John R Fullarton

Ann Gastroenterol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical burden of severe respiratory syncytial virus infection during the first 2 years of life in children born between 2000 and 2011 in Scotland.
Richard Thwaites, Scot Buchan, John Fullarton, Carole Morris, ElizaBeth Grubb

Eur J Pediatr· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between respiratory syncytial virus hospitalization in infancy and childhood asthma.
Jonathan Coutts, John Fullarton, Carole Morris, ElizaBeth Grubb, Scot Buchan

Pediatr Pulmonol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IBD2020 global forum: results of an international patient survey on quality of care.
Peter Irving, Johan Burisch, Richard Driscoll, Mats Olsson, John R Fullarton

Intest Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS]).
Xavier Carbonell-Estrany, Alberto Dall'Agnola, John R Fullarton, Barry S Rodgers-Gray, Elisa Girardi

Acta Paediatr· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants.
Maarten O Blanken, Bosco Paes, Evan J Anderson, Marcello Lanari, Margaret Sheridan-Pereira, John R Fullarton

Pediatr Pulmonol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons.
Evan J Anderson, Xavier Carbonell-Estrany, Maarten Blanken, Marcello Lanari, Margaret Sheridan-Pereira, John Fullarton

Pediatr Infect Dis J· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of birth weight amongst 33-35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysis.
Xavier Carbonell-Estrany, John R Fullarton, Katherine L Gooch, Jean-Bernard Gouyon, Marcello Lanari

J Matern Fetal Neonatal Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?
Xavier Carbonell-Estrany, John R Fullarton, Barry S Rodgers-Gray, Katherine L Gooch, Pamela G Vo

J Matern Fetal Neonatal Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' reply to Davis.
Ravi Jandhyala, John R Fullarton, Michael I Bennett

J Pain Symptom Manage· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of bisphosphonates in metastatic breast and prostate cancer and multiple myeloma: a mixed-treatment meta-analysis.
Carlo Palmieri, John R Fullarton, Janet Brown

Clin Cancer Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials.
Ravi Jandhyala, John R Fullarton, Michael I Bennett

J Pain Symptom Manage· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis